1. Comorbidity in young patients with juvenile systemic lupus erythematosus: how can we improve management?

   • Coziana Ciurtin
   • George A. Robinson
   • Elizabeth C. Jury

   Editorial 17 February 2022 Pages: 961 - 964

2. Linking physical activity with clinical, functional, and structural outcomes: an evidence map using the Osteoarthritis Initiative

   • Aleksandra R. Budarick
   • Rebecca F. Moyer

   Review Article 21 November 2021 Pages: 965 - 975

   

3. Prevalence of autoantibodies in pediatric patients with idiopathic pulmonary hemosiderosis: a scoping review of the literature in the period 1980–2021

   • Biplab K. Saha
   • Alyssa Bonnier
   • Nils T. Milman

   Review Article 24 January 2022 Pages: 977 - 990

   

4. Expert recommendations on early diagnosis and referral of axial spondyloarthritis in the Kingdom of Saudi Arabia

   • Hanan Al Rayes
   • Mansour Alazmi
   • Suzan Attar

   Review Article 08 January 2022 Pages: 991 - 1002

   

5. The incidence, risk factor, and time to develop rheumatologic diseases after isolated inflammatory eye diseases: a 12-year cohort study

   • Kittiwan Sumethkul
   • Indhira Urailert
   • Sukhum Silpa-archa

   Original Article 10 January 2022 Pages: 1003 - 1012

   

6. Varus-valgus knee laxity is related to a higher risk of knee osteoarthritis incidence and structural progression: data from the osteoarthritis initiative

   • Mingyang Li
   • Yi Zeng
   • Bin Shen

   Original Article 22 January 2022 Pages: 1013 - 1021

   

7. Comparison of chronic widespread pain prevalence with different criteria in two cohorts of rheumatoid arthritis

   • M. Aronsson
   • S. Bergman
   • M. L. E. Andersson

   Original Article Open access 23 November 2021 Pages: 1023 - 1032

8. Stachys schtschegleevii tea, matrix metalloproteinase, and disease severity in female rheumatoid arthritis patients: a randomized controlled clinical trial

   • Elham Mirtaheri
   • Alireza Khabbazi
   • Saeed Pirouzpanah

   Original Article 11 November 2021 Pages: 1033 - 1044

   

9. Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)

   • Ruediger B. Mueller
   • Hendrik Schulze-Koops
   • Johannes von Kempis

   Original Article Open access 01 January 2022 Pages: 1045 - 1055

   

10. Machine learning to identify immune-related biomarkers of rheumatoid arthritis based on WGCNA network

    • Yulan Chen
    • Ruobing Liao
    • Lingyu Fu

    Original Article 12 November 2021 Pages: 1057 - 1068

    

11. Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study

    • Ana Rita Prata
    • Mariana Luís
    • Luís Sousa Inês

    Original Article 16 November 2021 Pages: 1069 - 1078

    

12. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus

    • Carlos E. Insfrán
    • Nadia E. Aikawa
    • Eloisa Bonfa

    Brief Report 16 November 2021 Pages: 1079 - 1085

    

13. The aberrant expression of CD45 isoforms and levels of sex hormones in systemic lupus erythematosus

    • Zhaoxia Dong
    • Bin Zhang
    • Zhongjing Su

    Original Article 22 January 2022 Pages: 1087 - 1093

    

14. Early identification of axial spondyloarthritis in a multi-ethnic Asian population

    • Ling Xiang
    • Warren Fong
    • Julian Thumboo

    Original Article 08 October 2021 Pages: 1095 - 1103

15. Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset

    • Kathleen Tymms
    • Belinda E. Butcher
    • on behalf of the OPAL consortium

    Original Article Open access 26 November 2021 Pages: 1105 - 1114

16. The disease burden of axial spondyloarthritis: through a gendered lens

    • Sara Khan
    • Divya Shridharmurthy
    • Shao-Hsien Liu

    Original Article 06 January 2022 Pages: 1115 - 1124

17. Validation of the psoriasis epidemiology screening tool (PEST) and the new early arthritis for psoriatic patients (EARP) in pediatric population: pilot study

    • Hadar Gavra
    • Irit Tirosh
    • Butbul Aviel Yonatan

    Original Article 14 January 2022 Pages: 1125 - 1130

    

18. Repolarization in systemic sclerosis: a meta-analysis

    • Yehuda Wexler
    • Udi Nussinovitch

    Original Article 29 November 2021 Pages: 1131 - 1137

    

19. Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohort

    • Raquel Freitas
    • Patrícia Martins
    • Maria José Santos

    Brief Report 20 November 2021 Pages: 1139 - 1144

    

20. The effects of resistance training in patients with primary Sjogren’s syndrome

    • Luciana Paula Dardin
    • Ana Beatriz Andreo Garcia
    • Virginia Fertnandes Moça Trevisani

    Original Article 08 November 2021 Pages: 1145 - 1152

    

21. Risk factors for progression of interstitial lung disease in Sjögren’s syndrome: a single-centered, retrospective study

    • Shi-Hao He
    • Yu-Jie He
    • Tian-Fang Li

    Original Article 10 November 2021 Pages: 1153 - 1161

    

22. Diminished natural killer T-like cells correlates with aggravated primary Sjögren’s syndrome

    • Xinhua Zhou
    • Qingxiang Li
    • Yingni Li

    Original Article 21 January 2022 Pages: 1163 - 1168

    

23. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis

    • Hazan Karadeniz
    • Aslıhan Avanoğlu Güler
    • Şeminur Haznedaroğlu

    Original Article 11 January 2022 Pages: 1169 - 1176

    

24. Coronavirus disease 2019 in patients with Behcet’s disease: a report of 59 cases in Iran

    • Farhad Shahram
    • Kamal Esalatmanesh
    • Shayan Mostafaei

    Original Article 29 November 2021 Pages: 1177 - 1183

25. Illness perception and treatment experience in patients with gout: a descriptive qualitative study

    • Qin Li
    • Ting Liu
    • Xiuxin Miao

    Original Article 11 January 2022 Pages: 1185 - 1195

    

26. Correction to: Illness perception and treatment experience in patients with gout: a descriptive qualitative study

    • Qin Li
    • Ting Liu
    • Xiuxin Miao

    Correction 21 January 2022 Pages: 1197 - 1197

27. A clinical model for predicting knee replacement in early-stage knee osteoarthritis: data from osteoarthritis initiative

    • Rongjie Wu
    • Yuanchen Ma
    • Guangtao Fu

    Original Article 21 November 2021 Pages: 1199 - 1210

    

28. Clinical joints manifestations in patients with psoriatic arthritis on musculoskeletal ultrasound

    • Hang Zhou
    • Lanyan Qiu
    • Jian Zhao

    Original Article 03 November 2021 Pages: 1211 - 1218

    

29. Post-operative outcomes of inflammatory thoracic aortitis: a study of 41 patients from a cohort of 1119 surgical cases

    • Hugh C. Caterson
    • Ang Li
    • Anthony M. Sammel

    Brief Report 03 November 2021 Pages: 1219 - 1226

    

30. Explaining the gap in the experience of depression among arthritis patients

    • Manasi M. Mittinty
    • James M. Elliott
    • Murthy N. Mittinty

    Original Article 07 January 2022 Pages: 1227 - 1233

    

31. Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study

    • Chao Gao
    • Hua Zhong
    • Tian Liu

    Original Article 24 January 2022 Pages: 1235 - 1240

32. The manifestation of myositis in tick-borne encephalitis as a prophet of severe disease course: a rare case report

    • Marija Montvydaite
    • Goda Seskute
    • Irena Butrimiene

    Case Based Review 13 January 2022 Pages: 1241 - 1245

33. Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options

    • Riccardo Bixio
    • Davide Bertelle
    • Ombretta Viapiana

    Case Based Review Open access 14 January 2022 Pages: 1247 - 1254

    

34. Hiker’s feet

    • Rashmi Roongta
    • Sumantro Mondal
    • Alakendu Ghosh

    Clinical Image 05 October 2021 Pages: 1255 - 1256

    

35. UBA1 gene mutation in giant cell arteritis

    • Julien Rossignol
    • Christophe Marzac
    • on behalf MINHEMON

    Letters of Biomedical and Clinical Research 30 January 2022 Pages: 1257 - 1259

36. Fetal exposure to canakinumab: a report of three pregnancies

    • Ufuk İlgen
    • Şahin Eyüpoğlu
    • Orhan Küçükşahin

    Letters of Biomedical and Clinical Research 12 January 2022 Pages: 1261 - 1263

37. Can Raynaud’s phenomenon be defined as a subtype of primary Sjögren’s syndrome? Comments on “Clinical features and risk factors of Raynaud’s phenomenon in primary Sjögren’s syndrome”

    • Caiqun Chen
    • Yan Liang
    • Zaixing Yang

    Letter to the Editor 21 January 2022 Pages: 1265 - 1266

38. Comment on: Can Raynaud’s phenomenon be defined as a subtype of primary Sjögren’s syndrome? Comments on “Clinical features and risk factors of Raynaud’s phenomenon in primary Sjögren’s syndrome” Reply

    • Lin Wei
    • Yang Liu
    • Zhang Fengxiao

    Letter to the Editor 04 January 2022 Pages: 1267 - 1268

39. Correction to: Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real‑world study

    • T. Korotaeva
    • O. Dina
    • A. Deodhar

    Correction Open access 27 January 2022 Pages: 1269 - 1269